Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Genpharmasec Limited has submitted a quarterly compliance certificate to BSE from its Registrar and Share Transfer Agent (RTA), Satellite Corporate Services Pvt. Ltd., as required under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The certificate confirms that any physical share certificates received for dematerialization have been duly listed, mutilated, cancelled, and the depository has been recorded as the registered owner. Importantly, the RTA confirms that no physical share certificates were received for dematerialization during the quarter, meaning there were zero conversions from physical to demat form. This is a routine regulatory compliance filing with no impact on business operations or shareholding structure.
This is a standard quarterly compliance filing with no material impact on shareholders or the stock price. It simply confirms regulatory adherence and indicates no share dematerialization activity occurred during the quarter.